1. Pretreatment of liver grafts in vivo by γ-aminobutyric acid receptor regulation reduces cold ischemia/warm reperfusion injury in rat.
- Author
-
Hori T, Gardner LB, Hata T, Chen F, Baine AM, Uemoto S, and Nguyen JH
- Subjects
- Animals, Ataxia Telangiectasia Mutated Proteins metabolism, Bicuculline administration & dosage, Cold Ischemia adverse effects, DNA Repair drug effects, Histones metabolism, Lipid Peroxidation drug effects, Male, Muscimol administration & dosage, Oxidative Stress drug effects, Rats, Rats, Inbred Lew, Reperfusion Injury metabolism, Reperfusion Injury pathology, Signal Transduction drug effects, Warm Ischemia adverse effects, GABA Agonists administration & dosage, GABA Antagonists administration & dosage, Liver Transplantation methods, Reperfusion Injury prevention & control
- Abstract
Background: Gamma-aminobutyric acid (GABA) is found throughout the body. The regulation of GABA receptor (GABAR) reduces oxidative stress (OS). Ischemia/reperfusion injury after orthotopic liver transplantation (OLT) causes OS-induced graft damage. The effects of GABAR regulation in donors in vivo were investigated., Material and Methods: Donor rats received saline, a GABAR agonist or GABAR antagonist 4 h before surgery. Recipient rats were divided into four groups according to the donor treatments: laparotomy, OLT with saline, OLT with GABAR agonist and OLT with GABAR antagonist. Histopathological, biochemical and immunohistological examinations were performed at 6, 12 and 24 h after OLT. Protein assays were performed at 6 h after OLT. The 4-hydroxynonenal (4-HNE), ataxia-telangiectasia mutated kinase (ATM), phosphorylated histone H2AX (gammaH2AX), phosphatidylinositol-3 kinase (PI3K), Akt and superoxide dismutase (SOD) were assessed by western blot analysis., Results: In the univariate analysis, histopathological and biochemical profiles verified that the GABAR agonist reduced graft damage. Immunohistology revealed that the GABAR agonist prevented the induction of apoptosis. Measurement of 4-4-HNE levels confirmed OS-induced damage after OLT, and the GABAR agonist improved this damage. In the gammaH2AX, PI3K, Akt and antioxidant enzymes (SODs), ATM and H2AX were greatly increased after OLT, and were reduced by the GABAR agonist. In the multivariate analyses between multiple groups, histopathological assessment, aspartate aminotransferase level, immunohistological examinations for apoptotic induction and gammaH2AX showed statistical differences., Conclusions: A specific agonist demonstrated regulation of GABAR in vivo in the liver. This activation in vivo reduced OS after OLT via the ATM/H2AX pathway.
- Published
- 2013
- Full Text
- View/download PDF